drugset / Trial / NCT00599248
Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee
RandomizedParallel-groupSingle-blindTreatment
Summary
The study is being conducted to investigate the safety and activity of TissueGene-C injected into the knee joint of patients with chronic degenerative joint disease (DJD) who will be undergoing total knee replacement.
Timeline
- Start
- 2007-01
- Primary completion
- 2009-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TissueGene-C | Cell therapy | 3e+06 cells | Other |
| Subject | TissueGene-C | Cell therapy | 1e+07 cells | Other |
| Subject | TissueGene-C | Cell therapy | 3e+07 cells | Other |